
Daniel Pm Wicklund
Examiner (ID: 10795, Phone: (571)270-7508 , Office: P/2833 )
| Most Active Art Unit | 2833 |
| Art Unit(s) | 2833, 2844 |
| Total Applications | 376 |
| Issued Applications | 278 |
| Pending Applications | 0 |
| Abandoned Applications | 98 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19195358
[patent_doc_number] => 11992577
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-28
[patent_title] => Adhesive for surgical staple line reinforcement
[patent_app_type] => utility
[patent_app_number] => 17/443470
[patent_app_country] => US
[patent_app_date] => 2021-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 10
[patent_no_of_words] => 11772
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17443470
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/443470 | Adhesive for surgical staple line reinforcement | Jul 26, 2021 | Issued |
Array
(
[id] => 20663556
[patent_doc_number] => 12605305
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-04-21
[patent_title] => Application of citrate metal salt in endodontic treatment, and formulation obtained by preparation
[patent_app_type] => utility
[patent_app_number] => 18/025339
[patent_app_country] => US
[patent_app_date] => 2021-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 27
[patent_no_of_words] => 2759
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18025339
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/025339 | Application of citrate metal salt in endodontic treatment, and formulation obtained by preparation | Jul 18, 2021 | Issued |
Array
(
[id] => 18626624
[patent_doc_number] => 20230285421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO GENETIC ABNORMALITIES
[patent_app_type] => utility
[patent_app_number] => 18/005845
[patent_app_country] => US
[patent_app_date] => 2021-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4163
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18005845
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/005845 | USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO GENETIC ABNORMALITIES | Jul 14, 2021 | Abandoned |
Array
(
[id] => 19290481
[patent_doc_number] => 12029820
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-09
[patent_title] => Sustained release compositions of 4-aminopyridine
[patent_app_type] => utility
[patent_app_number] => 17/374285
[patent_app_country] => US
[patent_app_date] => 2021-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 27233
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17374285
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/374285 | Sustained release compositions of 4-aminopyridine | Jul 12, 2021 | Issued |
Array
(
[id] => 17368209
[patent_doc_number] => 20220023261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/371774
[patent_app_country] => US
[patent_app_date] => 2021-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20143
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17371774
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/371774 | Pharmaceutical combinations for the treatment of cancer | Jul 8, 2021 | Issued |
Array
(
[id] => 17183682
[patent_doc_number] => 20210330567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => COMPOUNDS AND COMPOSITIONS FOR USE
[patent_app_type] => utility
[patent_app_number] => 17/370074
[patent_app_country] => US
[patent_app_date] => 2021-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9799
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17370074
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/370074 | Compounds and compositions for use | Jul 7, 2021 | Issued |
Array
(
[id] => 17297721
[patent_doc_number] => 20210393560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => ADMINISTRATION OF R-BETA-HYDROXYBUTYRATE AND RELATED COMPOUNDS IN HUMANS
[patent_app_type] => utility
[patent_app_number] => 17/367206
[patent_app_country] => US
[patent_app_date] => 2021-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10706
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17367206
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/367206 | Administration of R-beta-hydroxybutyrate and related compounds in humans | Jul 1, 2021 | Issued |
Array
(
[id] => 17297711
[patent_doc_number] => 20210393550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => Formulation for Inhibiting Formation of 5-HT2B Agonists and Methods of Using Same
[patent_app_type] => utility
[patent_app_number] => 17/365118
[patent_app_country] => US
[patent_app_date] => 2021-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8946
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17365118
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/365118 | Formulation for inhibiting formation of 5-HT | Jun 30, 2021 | Issued |
Array
(
[id] => 17334744
[patent_doc_number] => 20220001075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => FLOWABLE HEMOSTATIC SUSPENSION
[patent_app_type] => utility
[patent_app_number] => 17/365795
[patent_app_country] => US
[patent_app_date] => 2021-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41555
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17365795
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/365795 | Flowable hemostatic suspension | Jun 30, 2021 | Issued |
Array
(
[id] => 18675029
[patent_doc_number] => 20230312578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => 6H-INDOLO[2,3-B]QUINOXALINE DERIVATIVES USEFUL IN THERAPY
[patent_app_type] => utility
[patent_app_number] => 18/003750
[patent_app_country] => US
[patent_app_date] => 2021-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8550
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18003750
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/003750 | 6H-INDOLO[2,3-B]QUINOXALINE DERIVATIVES USEFUL IN THERAPY | Jun 28, 2021 | Pending |
Array
(
[id] => 18792599
[patent_doc_number] => 11826332
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-28
[patent_title] => Antimicrobial compositions and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/360966
[patent_app_country] => US
[patent_app_date] => 2021-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 19883
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17360966
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/360966 | Antimicrobial compositions and uses thereof | Jun 27, 2021 | Issued |
Array
(
[id] => 17140320
[patent_doc_number] => 20210308331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => MACROSCOPICALLY ALIGNABLE, INJECTABLE, SOFT HYDROGEL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/350695
[patent_app_country] => US
[patent_app_date] => 2021-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12511
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17350695
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/350695 | Macroscopically alignable, injectable, soft hydrogel composition | Jun 16, 2021 | Issued |
Array
(
[id] => 18509901
[patent_doc_number] => 20230225986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => USE OF CANNABIDIOL IN THE TREATMENT OF EPILEPSY
[patent_app_type] => utility
[patent_app_number] => 18/002437
[patent_app_country] => US
[patent_app_date] => 2021-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5303
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18002437
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/002437 | USE OF CANNABIDIOL IN THE TREATMENT OF EPILEPSY | Jun 15, 2021 | Pending |
Array
(
[id] => 19423196
[patent_doc_number] => 12082580
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-10
[patent_title] => Use of multiple charged cationic compounds derived from primary amines or polyamines for microbial fouling control in a water system
[patent_app_type] => utility
[patent_app_number] => 17/304041
[patent_app_country] => US
[patent_app_date] => 2021-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 22116
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 203
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17304041
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/304041 | Use of multiple charged cationic compounds derived from primary amines or polyamines for microbial fouling control in a water system | Jun 13, 2021 | Issued |
Array
(
[id] => 17140065
[patent_doc_number] => 20210308076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => Methods For The Treatment Of Depression
[patent_app_type] => utility
[patent_app_number] => 17/345395
[patent_app_country] => US
[patent_app_date] => 2021-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13845
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17345395
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/345395 | Methods for the treatment of depression | Jun 10, 2021 | Issued |
Array
(
[id] => 18931020
[patent_doc_number] => 11883414
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-30
[patent_title] => Methods of reducing mammographic breast density and/or breast cancer risk
[patent_app_type] => utility
[patent_app_number] => 17/344052
[patent_app_country] => US
[patent_app_date] => 2021-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 60
[patent_no_of_words] => 48649
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17344052
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/344052 | Methods of reducing mammographic breast density and/or breast cancer risk | Jun 9, 2021 | Issued |
Array
(
[id] => 17974362
[patent_doc_number] => 11491199
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-11-08
[patent_title] => Anticoagulation activity of sulfated carboxymethyl cellulose/
[patent_app_type] => utility
[patent_app_number] => 17/342593
[patent_app_country] => US
[patent_app_date] => 2021-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 14
[patent_no_of_words] => 10603
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17342593
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/342593 | Anticoagulation activity of sulfated carboxymethyl cellulose/ | Jun 8, 2021 | Issued |
Array
(
[id] => 19649984
[patent_doc_number] => 12171744
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-24
[patent_title] => Pharmaceutical combinations for the treatment of cancer
[patent_app_type] => utility
[patent_app_number] => 17/337952
[patent_app_country] => US
[patent_app_date] => 2021-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 79
[patent_no_of_words] => 20176
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17337952
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/337952 | Pharmaceutical combinations for the treatment of cancer | Jun 2, 2021 | Issued |
Array
(
[id] => 19195262
[patent_doc_number] => 11992480
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-28
[patent_title] => Method for reducing side effects from administration of phosphodiesterase-4 inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/327236
[patent_app_country] => US
[patent_app_date] => 2021-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 13
[patent_no_of_words] => 13354
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17327236
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/327236 | Method for reducing side effects from administration of phosphodiesterase-4 inhibitors | May 20, 2021 | Issued |
Array
(
[id] => 18468721
[patent_doc_number] => 20230203003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => Notch Inhibitors and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/925917
[patent_app_country] => US
[patent_app_date] => 2021-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 107738
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -59
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17925917
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/925917 | Notch Inhibitors and Uses Thereof | May 20, 2021 | Abandoned |